Intriguingly, we observed that SPHK1- or MTA3-induced tumor proliferation was substantially suppressed by anti-PD-1 mAb treatment, as demonstrated by a reduction in the tumor growth rate (Fig. 5d–g and Supplementary Tables 7, 8). Here, SPHK1 is linked to neoplasm.